Understanding the presence and function of erythropoietin receptors on cancer cells

被引:39
作者
Lai, Stephen Y. [1 ]
Grandis, Jennifer R.
机构
[1] Univ Pittsburgh, Sch Med, Ctr Canc, Dept Otolaryngol, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Sch Med, Ctr Canc, Dept Pharmacol, Pittsburgh, PA USA
关键词
D O I
10.1200/JCO.2006.08.1190
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4675 / 4676
页数:2
相关论文
共 30 条
[1]   Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression [J].
Acs, G ;
Zhang, PJ ;
McGrath, CM ;
Acs, P ;
McBroom, J ;
Mohyeldin, A ;
Liu, SZ ;
Lu, HS ;
Verma, A .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1789-1806
[2]   ERYTHROPOIETIN HAS A MITOGENIC AND POSITIVE CHEMOTACTIC EFFECT ON ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LEE, ES ;
KESSIMIAN, N ;
LEVINSON, R ;
STEINER, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5978-5982
[3]  
Belenkov AI, 2004, MOL CANCER THER, V3, P1525
[4]   Activation of the transcription factor NF-κB by the erythropoietin receptor -: Structural requirements and biological significance [J].
Bittorf, T ;
Büchse, T ;
Sasse, T ;
Jaster, R ;
Brock, J .
CELLULAR SIGNALLING, 2001, 13 (09) :673-681
[5]  
Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO
[6]  
2-P
[7]   Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling [J].
Hanlon, PR ;
Fu, P ;
Wright, GL ;
Steenbergen, C ;
Arcasoy, MO ;
Murphy, E .
FASEB JOURNAL, 2005, 19 (08) :1323-+
[8]   Erythropoietin biology in cancer [J].
Hardee, ME ;
Arcasoy, MO ;
Blackwell, KL ;
Kirkpatrick, JP ;
Dewhirst, MW .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :332-339
[9]   Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial [J].
Henke, M ;
Laszig, R ;
Rübe, C ;
Schäfer, U ;
Haase, KD ;
Schilcher, B ;
Mose, S ;
Beer, KGT ;
Burger, U ;
Dougherty, C ;
Frommhold, H .
LANCET, 2003, 362 (9392) :1255-1260
[10]   Do erythropoietin receptors on cancer cells explain unexpected clinical findings? [J].
Henke, Michael ;
Mattern, Dominik ;
Pepe, Margaret ;
Bezay, Christina ;
Weissenberger, Christian ;
Werner, Martin ;
Pajonk, Frank .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4708-4713